This country profile provides an overview of Rwanda’s progress in reaching those in need of mass NTD treatment based on 2017 data.

*This includes all countries in Africa that are endemic for at least one of the five NTDs

Download country profile

Treatment coverage

Elephantiasis
N/A
Blinding trachoma
N/A
Intestinal worms
99%
Bilharzia
62%
River blindness
N/A
4.45 million people received treatment in Rwanda in 2017 0.88 mllion people did not receive treatment in Rwanda in 2017

Priorities for progress in Rwanda

  • Rwanda has the potential and political will to fully fund its national NTD programme.
  • It is encouraged to take steps to take full ownership of the national NTD programme and work towards elimination as appropriate.
  • Support the Expanded Special Project for Elimination of Neglected Tropical Diseases (ESPEN) established by WHO AFRO region for the elimination of these five diseases.

Elephantiasis

Rwanda does not require mass treatment for elephantiasis.

Blinding trachoma

Rwanda does not require mass treatment for blinding trachoma.

Intestinal worms

Treatment coverage decreased from 100% in 2016 to 99% in 2017.

Pre-sch and school-aged children needing treatment
4.45m
Pre-school and school-aged children receiving treatment
4.4m

Bilharzia

Treatment coverage was not reported in 2016 and 62% in 2017.

School-aged children needing treatment
1.52m
School-aged children receiving treatment
0.94m

River blindness

Rwanda does not require mass treatment for river blindness.

The ESPEN portal (a World Health Organization AFRO region project) provides maps and district-level data for the preventive chemotherapy diseases in Rwanda.